Therapeutics for COVID-19: established and in development
COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first recognised in late 2019, with over 30 000 000 cases and over 1 000 000 deaths reported by the end of September 2020. SARS-CoV-2 infection is usually associated with fever, cough, coryza, dyspnoea, anosmia, hea...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
CSIRO Publishing
2020-01-01
|
| Series: | Microbiology Australia |
| Online Access: | https://www.publish.csiro.au/ma/pdf/MA20058 |